Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Major hypercalcemia disclosing sarcoidosis]

C Mathis1, Y Maugars, P Vilon

  • 1Service de Rhumatologie, CHR Nantes, Hôpital Saint-Jacques.

La Revue De Medecine Interne
|April 1, 1993
PubMed
Summary

Sarcoidosis is a rare disease that can sometimes cause high calcium levels in the blood, known as hypercalcemia. This study reports a new case and reviews the literature on this unusual presentation. The authors suggest that granulomatous cells in sarcoidosis may overproduce a form of vitamin D, leading to elevated calcium. This condition can be managed with corticosteroids and sometimes hydroxychloroquine. The study emphasizes the importance of recognizing sarcoidosis in patients with unexplained hypercalcemia to aid in early diagnosis and treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A new boronate ester-based crosslinking strategy allows the design of nonswelling and long-term stable dynamic covalent hydrogels.

Biomaterials science·2023
Same author

Development and characterization of a humanized mouse model of osteoarthritis.

Osteoarthritis and cartilage·2022
Same author

'I was trying to get there, but I couldn't': social norms, vulnerability and lived experiences of home delivery in Mashonaland Central Province, Zimbabwe.

Health policy and planning·2021
Same author

Refractory lymphorrhoea of the neck treated with etilefrine.

European annals of otorhinolaryngology, head and neck diseases·2021
Same author

Systems toxicology meta-analysis of <i>in vitro</i> assessment studies: biological impact of a candidate modified-risk tobacco product aerosol compared with cigarette smoke on human organotypic cultures of the aerodigestive tract.

Toxicology research·2018
Same author

Clinical relevance of 3D gait analysis in patients with haemophilia.

Haemophilia : the official journal of the World Federation of Hemophilia·2018

Area of Science:

  • Endocrinology and metabolic disorders
  • Pulmonary and respiratory medicine
  • Immunology and autoimmune diseases

Background:

Hypercalcemia is a rare but significant clinical presentation in sarcoidosis. Prior research has shown that sarcoidosis can manifest with elevated serum calcium levels, though this is uncommon. Established knowledge includes the association between granulomatous diseases and vitamin D metabolism. No prior work had resolved the frequency of hypercalcemia as an initial symptom of sarcoidosis. This gap motivated the current analysis of case reports and literature. That uncertainty drove the need to clarify the physiopathological mechanisms involved. Researchers sought to determine how often sarcoidosis reveals itself through hypercalcemia. Understanding this connection could improve diagnostic approaches in patients with unexplained calcium elevation.

Purpose Of The Study:

This study aimed to investigate the clinical relevance of major hypercalcemia as a diagnostic clue for sarcoidosis. The specific problem is the rarity of this presentation, which may lead to delayed diagnosis. The motivation stems from the need to recognize sarcoidosis in patients with hypercalcemia of unknown origin. The authors propose that granulomatous cells may contribute to this phenomenon. This paper adds a new case to the limited existing literature. The goal is to highlight the diagnostic value of hypercalcemia in sarcoidosis. The authors suggest that clinicians should consider sarcoidosis when encountering isolated hypercalcemia. This approach may improve early detection and management of the disease.

Keywords:
Sarcoidosis diagnosisHypercalcemia causesVitamin D metabolismGranulomatous disease

Frequently Asked Questions

The authors propose that granulomatous cells overproduce 1-25 dihydroxyvitamin D3, which evades normal regulatory mechanisms.

The study suggests that sarcoidosis may be diagnosed based on clinical features and imaging when hypercalcemia is unexplained.

Corticosteroids may reduce granuloma activity and lower vitamin D metabolite production, thus managing hypercalcemia.

Hydroxychloroquine is used as an adjunct therapy in some cases to help manage sarcoidosis-related hypercalcemia.

Related Experiment Videos

Main Methods:

The researchers reviewed the literature to compile case reports of sarcoidosis presenting with hypercalcemia. They analyzed the frequency and clinical features of this association. The study included a new case report from their own clinical experience. The authors examined the physiopathological mechanisms underlying the condition. They focused on the role of granulomatous cells in vitamin D metabolism. The approach involved a systematic review of published cases and relevant studies. The authors compared the new case with previously reported instances. The analysis emphasized the overproduction of 1-25 dihydroxyvitamin D3 as a key factor.

Main Results:

The study identified five cases of sarcoidosis revealed by major hypercalcemia. The new case involved a patient with no prior history of sarcoidosis. Serum calcium levels were significantly elevated in all reported cases. The authors observed that hypercalcemia was an isolated finding in these patients. Granulomatous cells were found to produce excess 1-25 dihydroxyvitamin D3. This overproduction evades normal regulatory mechanisms. The condition responded to corticosteroid therapy in most cases. Hydroxychloroquine was used in some patients to manage symptoms.

Conclusions:

The authors conclude that sarcoidosis may present with major hypercalcemia as an initial symptom. This finding is rare but clinically important for early diagnosis. The physiopathology involves granulomatous cells producing excess vitamin D metabolites. The study suggests that clinicians should consider sarcoidosis in patients with unexplained hypercalcemia. Corticosteroid therapy appears effective in managing this condition. Hydroxychloroquine may be used as an adjunct in some cases. The authors propose that this presentation is under-recognized in clinical practice. Further case reports may help clarify the diagnostic value of hypercalcemia in sarcoidosis.

The study reports five cases, suggesting this presentation is exceptionally rare but clinically significant.

The authors suggest that clinicians should consider sarcoidosis in patients with unexplained hypercalcemia to improve early diagnosis.